Effects of probiotics, prebiotics, and synbiotics on messenger RNA expression of caveolin-1, NOS, and genes regulating oxidative stress in the terminal ileum of formula-fed neonatal rats

Pediatric Research

Volumn 67, Issue 5, 2010, Pages 526-531

  D'Souza, Antoni ^a   Fordjour, Lawrence ^a   Ahmad, Asma ^a   Cai, Charles ^a   Kumar, Dharmendra ^a   Valencia, Gloria ^a   Aranda, Jacob V ^a   Beharry, Kay D ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; EPIDERMAL GROWTH FACTOR; GLUTATHIONE PEROXIDASE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PREBIOTIC AGENT; PROBIOTIC AGENT; SOMATOMEDIN B; SOMATOMEDIN C; SUPEROXIDE DISMUTASE; SYNBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ARTIFICIAL MILK; CONTROLLED STUDY; FEMALE; GENE CONTROL; HISTOPATHOLOGY; ILEUM; NECROTIZING ENTEROCOLITIS; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AGING; ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; BODY SIZE; CAVEOLIN 1; ENTEROCOLITIS, NECROTIZING; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION; GLUTATHIONE PEROXIDASE; HUMANS; ILEUM; INFANT FORMULA; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PREBIOTICS; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUPEROXIDE DISMUTASE;

EID: 77951463666     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181d4ff2b     Document Type: Article

References (28)

1. Srinivasan PS, Brandler MD, D'Souza A 2008 Necrotizing enterocolitis. Clin Perinatol 35:251-272 (Pubitemid 351246701)
2. Levy RM, Prince JM, Billiar TR 2005 Nitric oxide: a clinical primer. Crit Care Med 33:S492-S495
3. Alderton WK, Cooper CE, Knowles RG 2001 Nitric oxide synthases: structure, function and inhibition. Biochem J 357:593-615 (Pubitemid 32735142)
4. Nathan C, Xie QW 1994 Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918 (Pubitemid 24292319)
5. Tepperman BL, Brown JF, Whittle BJ 1993 Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol 265:G214-G218
6. Ford H, Watkins S, Reblock K, Rowe M 1997 The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 32:275-282 (Pubitemid 27082170)
7. Beckman JS, Koppenol WH 1996 Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-C1437
8. Upperman JS, Potoka D, Grishin A, Hackam D, Zamora R, Ford HR 2005 Mechanisms of nitric oxide-mediated intestinal barrier failure in necrotizing enterocolitis. Semin Pediatr Surg 14:159-166 (Pubitemid 41111602)
9. Bautista AP, Spitzer JJ 1994 Inhibition of nitric oxide formation in vivo enhances superoxide release by the perfused liver. Am J Physiol 266:G783-G788 (Pubitemid 2103892)
10. Grande-García A, del Pozo MA 2008 Caveolin-1 in cell polarization and directional migration. Eur J Cell Biol 87:641-647
11. Hu G, Ye RD, Dinauer MC, Malik AB, Minshall RD 2008 Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury. Am J Physiol Lung Cell Mol Physiol 294:L178-L186
12. Salanueva IJ, Cerezo A, Guadamillas MC, del Pozo MA 2007 Integrin regulation of caveolin function. J Cell Mol Med 11:969-980
13. Warner BW, Warner BB 2005 Role of epidermal growth factor in the pathogenesis of neonatal necrotizing enterocolitis. Semin Pediatr Surg 14:175-180 (Pubitemid 41111604)
14. Hirai C, Ichiba H, Saito M, Shintaku H, Yamano T, Kusuda S 2002 Trophic effect of multiple growth factors in amniotic fluid or human milk on cultured human fetal small intestinal cells. J Pediatr Gastroenterol Nutr 34:524-528 (Pubitemid 34596221)
15. Maggi D, Biedi C, Segat D, Barbero D, Panetta D, Cordera R 2002 IGF-I induces caveolin 1 tyrosine phosphorylation and translocation in the lipid rafts. Biochem Biophys Res Commun 295:1085-1089
16. Lin HC, Hsu CH, Chen HL, Chung MY, Hsu JF, Lien RI, Tsao LY, Chen CH, Su BH 2008 Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter randomized controlled trial. Pediatrics 122:693-700
17. Khailova L, Dvorak K, Arganbright KM, Williams CS, Halpern MD, Dvorak B 2009 Changes in hepatic cell junctions structure during experimental necrotizing entero-colitis: effect of EGF treatment. Pediatr Res 66:140-144
18. Zani A, Ghionzoli M, Lauriti G, Cananzi M, Smith VV, Pierro A, De Coppi P, Eaton S 2010 Does intestinal permeability lead to organ failure in experimental necrotizing enterocolitis? Pediatr Surg Int 26:85-89
19. Liu Y, Zhu L, Fatheree NY, Liu X, Pacheco SE, Tatevian N, Rhoads JM 2009 Changes in intestinal toll-like receptors and cytokines precede histological injury in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 297:G442-G450
20. Repetto S, Salani B, Maggi D, Cordera R 2005 Insulin and IGF-I phosphorylate eNOS in HUVECs by a caveolin-1 dependent mechanism. Biochem Biophys Res Commun 337:849-852 (Pubitemid 41446991)
21. Tremblay E, Chailler P, Ménard D 2001 Coordinated control of fetal gastric epithelial functions by insulin-like growth factors and their binding proteins. Endocrinology 142:1795-1803 (Pubitemid 32405935)
22. Gordon PV 2009 Understanding intestinal vulnerability to perforation in the extremely low birth weight infant. Pediatr Res 65:138-144
23. Fruchtman S, Simmons JG, Michaylira CZ, Miller ME, Greenhalgh CJ, Ney DM, Lund PK 2005 Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells. Am J Physiol Gastrointest Liver Physiol 289:G342-G350
24. Murali SG, Nelson DW, Draxler AK, Liu X, Ney DM 2005 Insulin-like growth factor-I (IGF-I) attenuates jejunal atrophy in association with increased expression of IGF-I binding protein-5 in parenterally fed mice. J Nutr 135:2553-2559
25. Huo H, Guo X, Hong S, Jiang M, Liu X, Liao K 2003 Lipid rafts/caveolae are essential for insulin-like growth factor-1 receptor signaling during 3T3-L1 preadi-pocyte differentiation induction. J Biol Chem 278:11561-11569
26. Matthews LC, Taggart MJ, Westwood M 2008 Modulation of caveolin-1 expression can affect signalling through the phosphatidylinositol 3-kinase/Akt pathway and cellular proliferation in response to insulin-like growth factor I. Endocrinology 149:5199-5208
27. Bennett WR, Crew TE, Slack JM, Ward A 2003 Structural-proliferative units and organ growth: effects of insulin-like growth factor 2 on the growth of colon and skin. Development 130:1079-1088
28. Gordon PV, Herman AC, Marcinkiewicz M, Gaston BM, Laubach VE, Aschner JL 2007 A neonatal mouse model of intestinal perforation: Investigating the harmful synergism between glucocorticoids and indomethacin. J Pediatr Gastroenterol Nutr 45:509-519